Recourse

About Recourse

Recourse AI, a Manchester-based company founded in 2018, is developing an AI-powered learning and assessment platform for the healthcare and life sciences sectors. The company was co-founded by Dr. Scott Martin, who serves as CEO, and Dr. Maksim Belousov, the CTO. Dr. Martin's background as a physician and NHS Clinical Entrepreneur Fellow, combined with Dr. Belousov's PhD in artificial intelligence and natural language processing, provides the blend of clinical and technical expertise that underpins the company's mission.

The firm's core offering is a platform often described as a "flight simulator for clinicians," which utilizes conversational AI and digital human avatars to create realistic, interactive training scenarios. This technology allows healthcare professionals, including doctors, nurses, and students, to practice and enhance their patient interaction, diagnostic, and decision-making skills in a safe, virtual environment. The platform provides instant, personalized feedback and coaching, aligned with custom grading rubrics, to help scale training and assessment. It serves a client base that includes healthcare institutions, life science companies, and defense organizations, with integrations into existing Learning Management Systems (LMS) and CRM systems.

Recourse AI's business model is centered on providing this specialized training platform to organizations, addressing needs from internal team upskilling to broader healthcare professional and patient engagement. The technology is designed to be highly scalable, offering on-demand training that can be accessed anywhere. The platform features AI Patients for practicing clinical decision-making, AI Experts for scalable access to specialized knowledge, and AI Assistants that act as personal tutors. A significant milestone for the company was securing $4.3 million in seed funding in a round led by Par Equity, with participation from Northern Gritstone and others, to expand its engineering team and enter new markets. The company has also received a $1.2 million grant from NHS England's SBRI Healthcare initiative and is involved in a collaboration with the USC Keck School of Medicine.